• Thumbnail for Novavax
    39°08′14″N 77°13′36″W / 39.1371°N 77.2267°W / 39.1371; -77.2267 Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland...
    31 KB (2,841 words) - 13:22, 18 June 2024
  • Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    74 KB (5,621 words) - 06:11, 21 October 2024
  • Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO:...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • vaccines to stimulate the immune response. It was patented in 2020 by Novavax and is composed of nanoparticles from saponins extracted from Quillaja...
    6 KB (581 words) - 10:03, 10 October 2024
  • Serum Institute of India also reached an agreement with Novavax for the production of Novavax's NVX-CoV2373 (Covovax) vaccine for India and other low and...
    19 KB (1,604 words) - 11:36, 19 September 2024
  • Sputnik V, Janssen, Covaxin, Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of February 19, 2023, 166,423,405 total vaccine doses have been administered...
    128 KB (9,955 words) - 00:32, 16 August 2024
  • Thumbnail for Quillaja saponaria
    1007/s12026-018-8991-x. PMC 5899102. "Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial" (Press release). Novavax. Jan 28, 2021. "Product Monograph:Arexvy"...
    8 KB (853 words) - 04:19, 16 September 2024
  • Thumbnail for Operation Warp Speed
    2020. Retrieved December 20, 2020. "Novavax Announces $1.6 Billion Funding from Operation Warp Speed". Novavax. July 7, 2020. Archived from the original...
    71 KB (5,872 words) - 02:08, 19 October 2024
  • initially teamed with Novavax Inc., a bio-technology company also based in Gaithersburg, MD., in the development and manufacture of the Novavax COVID-19 vaccine...
    66 KB (6,852 words) - 21:21, 28 July 2024
  • Thumbnail for Michael A. McManus Jr.
    White House Communications Director from 1984 to 1985 and now Director of Novavax. Steven R. Weisman (June 25, 1982). "White House - Mixed Signals Fray Nerves...
    2 KB (57 words) - 06:48, 17 March 2024